Different vasoactive effects of chronic endothelial and neuronal NO-synthase inhibition in young Wistar rats

[1]  I. Bernátová,et al.  L-NAME in the cardiovascular system — nitric oxide synthase activator? , 2012, Pharmacological reports : PR.

[2]  U. Kukongviriyapan,et al.  Tetrahydrocurcumin alleviates hypertension, aortic stiffening and oxidative stress in rats with nitric oxide deficiency , 2012, Hypertension Research.

[3]  B. Dahlöf,et al.  Direct Angiotensin II Type 2 Receptor Stimulation in N&ohgr;-Nitro-L-Arginine-Methyl Ester–Induced Hypertension: The Effect on Pulse Wave Velocity and Aortic Remodeling , 2012, Hypertension.

[4]  J. Castania,et al.  Hemodynamic responses to aortic depressor nerve stimulation in conscious L-NAME-induced hypertensive rats. , 2011, American journal of physiology. Regulatory, integrative and comparative physiology.

[5]  H. Salgado,et al.  Sympathetic activity is not increased in L-NAME hypertensive rats. , 2010, American journal of physiology. Regulatory, integrative and comparative physiology.

[6]  S. Cacanyiova,et al.  Effect of chronic nNOS inhibition on blood pressure, vasoactivity, and arterial wall structure in Wistar rats. , 2009, Nitric oxide : biology and chemistry.

[7]  S. Cacanyiova,et al.  Hypotrophic effect of long-term neuronal NO-synthase inhibition on heart and conduit arteries of the Wistar rats. , 2009, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[8]  A. Osuna,et al.  Effects of chronic treatment with 7-nitroindazole in hyperthyroid rats. , 2006, American journal of physiology. Regulatory, integrative and comparative physiology.

[9]  Kazuki Nakamura,et al.  Evaluation of blood pressure measured by tail-cuff methods (without heating) in spontaneously hypertensive rats. , 2006, Biological & pharmaceutical bulletin.

[10]  J. Rutledge,et al.  Synergistic effect of angiotensin II and nitric oxide synthase inhibitor in increasing aortic stiffness in mice. , 2006, American journal of physiology. Heart and circulatory physiology.

[11]  G. Rossoni,et al.  Angiotensin II type 1 receptor antagonism improves endothelial vasodilator function in L-NAME-induced hypertensive rats by a kinin-dependent mechanism , 2006, Journal of hypertension.

[12]  C. Castillo,et al.  Impairment of smooth muscle function of rat thoracic aorta in an endothelium‐independent manner by long‐term administration of NG‐nitro‐l‐arginine methyl ester , 2004, Fundamental & clinical pharmacology.

[13]  P. Babál,et al.  Red wine polyphenols prevent cardiovascular alterations in L-NAME-induced hypertension , 2004, Journal of hypertension.

[14]  F. Kristek,et al.  Hypotrophy of conduit artery walls of the offspring of nitric oxide-defective rats. , 2004, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[15]  J. Sainz,et al.  Chronic Blockade of Neuronal Nitric Oxide Synthase Does Not Affect Long‐Term Control of Blood Pressure in Normal, Saline‐Drinking or Deoxycorticosterone‐Treated Rats , 2003, Experimental physiology.

[16]  P. Babál,et al.  Wine polyphenols improve cardiovascular remodeling and vascular function in NO-deficient hypertension. , 2002, American journal of physiology. Heart and circulatory physiology.

[17]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[18]  N Toda,et al.  Relatively selective neuronal nitric oxide synthase inhibition by 7-nitroindazole in monkey isolated cerebral arteries. , 2001, European journal of pharmacology.

[19]  F. Ruiz-Marcos,et al.  Mechanisms of the increased pressor response to vasopressors in the mesenteric bed of nitric oxide-deficient hypertensive rats. , 2001, European journal of pharmacology.

[20]  V. López‐Miranda,et al.  Alpha-vascular responses after short-term and long-term inhibition of nitric oxide synthesis. , 2001, Journal of cardiovascular pharmacology.

[21]  F. Kristek,et al.  Functional and morphological pattern of vascular responses in two models of experimental hypertension. , 2001, Experimental and clinical cardiology.

[22]  T. Hortobágyi,et al.  Functional importance of neuronal nitric oxide synthase in the endothelium of rat basilar arteries , 2000, Brain Research.

[23]  A. Takeshita,et al.  Angiotensin in the nucleus tractus solitarii contributes to neurogenic hypertension caused by chronic nitric oxide synthase inhibition. , 2000, Hypertension.

[24]  F. Kristek,et al.  Pentaerythrityl tetranitrate attenuates structural changes in conduit arteries evoked by long‐term NO‐synthase inhibition , 2000, British journal of pharmacology.

[25]  M. Kähönen,et al.  Arterial function in nitric oxide-deficient hypertension: influence of long-term angiotensin II receptor antagonism. , 1999, Cardiovascular research.

[26]  J. Zicha,et al.  Ontogenetic aspects of hypertension development: analysis in the rat. , 1999, Physiological reviews.

[27]  M. Kimura,et al.  The contribution of nitric oxide to renal vascular wall thickening in rats with l-NAME-induced hypertension , 1998, Virchows Archiv.

[28]  F. Luft,et al.  Chronic nitric oxide inhibition with l-NAME: effects on autonomic control of the cardiovascular system. , 1998, American journal of physiology. Regulatory, integrative and comparative physiology.

[29]  J. Gogusev,et al.  Nitric oxide and the renin angiotensin system: contributions to blood pressure in the young rat , 1997, Pediatric Nephrology.

[30]  J. Pittner,et al.  Increased blood pressure in rats after long-term inhibition of the neuronal isoform of nitric oxide synthase. , 1997, The Journal of clinical investigation.

[31]  M. Gerová,et al.  Developmental dynamics of endothelial and neurogenic control of canine thoracic aorta , 1997, Mechanisms of Ageing and Development.

[32]  J. Michel,et al.  In vitro alteration of aortic vascular reactivity in hypertension induced by chronic NG-nitro-L-arginine methyl ester. , 1996, Hypertension.

[33]  G. Sancesario,et al.  Evidence from its cardiovascular effects that 7-nitroindazole may inhibit endothelial nitric oxide synthase in vivo. , 1996, European journal of pharmacology.

[34]  D. Henrion,et al.  Vascular reactivity in mesenteric resistance arteries following chronic nitric oxide synthase inhibition in Wistar rats , 1996, British journal of pharmacology.

[35]  I. Varga,et al.  Remodelling of septal branch of coronary artery and carotid artery in L-NAME treated rats. , 1996, Physiological research.

[36]  T. Lüscher,et al.  L-NAME hypertension alters endothelial and smooth muscle function in rat aorta. Prevention by trandolapril and verapamil. , 1995, Hypertension.

[37]  J. Raj,et al.  Endothelium-derived nitric oxide plays a larger role in pulmonary veins than in arteries of newborn lambs. , 1995, Circulation research.

[38]  E. Schiffrin,et al.  Resistance artery structure and neuroeffector mechanisms in hypertension induced by inhibition of nitric oxide synthase. , 1994, American journal of hypertension.

[39]  M. Nakane,et al.  Isoforms of nitric oxide synthase: functions in the cardiovascular system. , 1993, European heart journal.

[40]  J. Morton,et al.  Persistent hypertension following inhibition of nitric oxide formation in the young Wistar rat: role of renin and vascular hypertrophy , 1993, Journal of hypertension.

[41]  S. L. Hart,et al.  Characterization of the novel nitric oxide synthase inhibitor 7‐nitro indazole and related indazoles: antinociceptive and cardiovascular effects , 1993, British journal of pharmacology.

[42]  R. Zatz,et al.  Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension. , 1992, Hypertension.